A Phase 2a study evaluating the safety, tolerability, pharmacokinetics, and central nervous system activity of CY6463 when administered to participants with Alzheimer’s disease with vascular pathology

Autor:	Chad Glasser, Jennifer Chickering, Phebe Wilson, Emily Florine, Chris Winrow, Chris Wright
Rok vydání:	2021
Předmět:	Psychiatry and Mental health Cellular and Molecular Neuroscience Developmental Neuroscience Epidemiology Health Policy Neurology (clinical) Geriatrics and Gerontology
Zdroj:	Alzheimer's & Dementia. 17
ISSN:	1552-5279 1552-5260
DOI:	10.1002/alz.054463
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::b96a60301f67176793bd516507b7411c https://doi.org/10.1002/alz.054463 Zobrazit plný text záznamu